Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation

被引:146
作者
Gaughan, L
Logan, IR
Neal, DE
Robson, CN
机构
[1] Newcastle Univ, Sch Med, Prostate Res Grp, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Univ Cambridge, MRC Canc Cell Unit, Cambridge CB2 2X2, England
基金
英国医学研究理事会;
关键词
D O I
10.1093/nar/gki141
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The androgen receptor (AR) is a member of the nuclear hormone receptor family of transcription factors and plays a critical role in regulating the expression of genes involved in androgen-dependent and -independent tumour formation. Regulation of the AR is achieved by alternate binding of either histone acetyltransferase (HAT)-containing co-activator proteins, or histone deacetylase 1 (HDAC1). Factors that control AR stability may also constitute an important regulatory mechanism, a notion that has been confirmed with the finding that the AR is a direct target for Mdm2-mediated ubiquitylation and proteolysis. Using chromatin immunoprecipitation (ChIP) and re-ChIP analyses, we show that Mdm2 associates with AR and HDAC1 at the active androgen-responsive PSA promoter in LNCaP prostate cancer cells. Furthermore, we demonstrate that Mdm2-mediated modification of AR and HDAC1 catalyses protein destabilization and attenuates AR sactivity, suggesting that ubiquitylation of the AR and HDAC1 may constitute an additional mechanism for regulating AR function. We also show that HDAC1 and Mdm2 function co-operatively to reduce AR-mediated transcription that is attenuated by the HAT activity of the AR co-activator Tip60, suggesting interplay between acetylation status and receptor ubiquitylation in AR regulation. In all, our data indicates a novel role for Mdm2 in regulating components of the AR transcriptosome.
引用
收藏
页码:13 / 26
页数:14
相关论文
共 57 条
  • [1] Molecular genetics of prostate cancer
    Abate-Shen, C
    Shen, MM
    [J]. GENES & DEVELOPMENT, 2000, 14 (19) : 2410 - 2434
  • [2] The contribution of the RING finger domain of MDM2 to cell cycle progression
    Argentini, M
    Barboule, N
    Wasylyk, B
    [J]. ONCOGENE, 2000, 19 (34) : 3849 - 3857
  • [3] The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
    Argentini, M
    Barboule, N
    Wasylyk, B
    [J]. ONCOGENE, 2001, 20 (11) : 1267 - 1275
  • [4] Tip60 is a nuclear hormone receptor coactivator
    Brady, ME
    Ozanne, DM
    Gaughan, L
    Waite, I
    Cook, S
    Neal, DE
    Robson, CN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) : 17599 - 17604
  • [5] Mechanisms of androgen receptor activation and function
    Brinkmann, AO
    Blok, LJ
    de Ruiter, PE
    Doesburg, P
    Steketee, K
    Berrevoets, CA
    Trapman, J
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1999, 69 (1-6) : 307 - 313
  • [6] TSG101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination
    Burgdorf, S
    Leister, P
    Scheidtmann, KH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (17) : 17524 - 17534
  • [7] Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO
  • [8] 2-Q
  • [9] Androgen receptor - an update of mechanisms of action in prostate cancer
    Culig, Z
    Hobisch, A
    Bartsch, G
    Klocker, H
    [J]. UROLOGICAL RESEARCH, 2000, 28 (04): : 211 - 219
  • [10] Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA
    Dai, JL
    Burnstein, KL
    [J]. MOLECULAR ENDOCRINOLOGY, 1996, 10 (12) : 1582 - 1594